Thyroid
-
(122-18) Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors,
RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (Phase 2 clinical trial, appropriate for patients with medullary thyroid cancer.)
-
(140-18) A Study of Cabozantinib Compared With Placebo in Subjects With
Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed
After Prior VEGFR-targeted Therapy (Phase 3 clinical trial, appropriate for patients with thyroid cancer.)
-
(167-17) Caris ctDNA Validation Project (Research study, appropriate for
patients with all solid tumors.)
-
(172-17) Iodine I-131 With or Without Selumetinib in Treating Patients
With Recurrent or Metastatic Thyroid Cancer (Phase 2 clinical trial, appropriate for patients with some types of thyroid cancer.)
-
(175-17)
A randomized phase II study comparing selumetinib to placebo for enhancing
the clinical efficacy of radioactive iodine (RAI) for recurrent/metastatic
thyroid cancers that retain RAI uptake (Phase 2 clinical trial, appropriate for patients with thyroid cancer.)
Principal Investigator: Michael J. Demeure, M.D., F.A.C.S., F.A.C.E.;
Sub-Principal Investigator: George B. Semeniuk, M.D.
-
(180-18) AO-176 in Multiple Solid Tumor Malignancies (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
-
(211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate
Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
Certain clinical trials may not be listed on ClinicalTrials.gov. To learn
more about these or other clinical trials, please call 949-764-5543 or
contact us online.